European Companies Search Engine
MD: Paul A. Mulholland, Ruth Wessendorff · PPA (2) · Control: inVentiv Health Holdings Germany GmbH · Control: inVentiv Health Holdings Germany GmbH · Merger: INC Research GmbH, inVentiv Health … … Hrb18 Sept 2019 German Trade Register Announcement, Germany (17/09/2019)
Overview
Text
HRB 251564: Syneos Health Germany GmbH, Munich, Stefan-George-Ring 6, 81929 München. GmbH. Partnership agreement of May 12, 2000, last amended on April 11, 2013. The shareholders meeting of August 23, 2019 decided to amend Section 1 (Company, previously 'inVentiv Health Germany GmbH') 2 (headquarters, previously Neu-Isenburg, District Court of Offenbach am Main HRB 47030) of the Articles of Association. Business address: Stefan-George-Ring 6, 81929 München. The object of the company is to provide counselling and other services in the field of clinical research. This includes in particular data management, drug monitoring, health economics and results research services, project management and other administrative services; the organisation of test centres to conduct clinical trials on authorised and investigative medicines, import, packaging, dispatch, labelling and distribution of medicines; collecting laboratory samples from clinical trial sites; monitoring, recruiting and training of clinical research staff; the schools of clinical trial staff with regard to the conditions for drug control and the use of test and evaluation systems, including the provision of the appropriate materials; the review of potential clinical testing centres and the submission of all regulatory-required applications for new research projects; the recruitment and provision of employees to pharmaceutical and medical device companies and the provision of advisory and other support services and related aids to doctors, hospitals, employers, insurers, health insurance funds and other healthcare institutions or organisations. Share capital: EUR 26,000.00. If only one managing director is appointed, he represents the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Directors: Mulholland, Paul Andrew, Dockenfield/Surrey/ United Kingdom, *??.??.????; Wessendorff, Ruth, Billingbear, Wokingham/United Kingdom, *??.??.????, each with individual representatives; with the power to enter into legal transactions on behalf of the company in its own name or as a representative of a third party. individual procuratorate with the power to enter into legal transactions on behalf of the company as a representative of a third party: Lang, Alexandra, Worms, *??.??.????; ???????, ???????? ??????? ?????????, Hillegom/ Netherlands, *??.??.????. With the inVentiv Health Holdings Germany GmbH, Neu-Isenburg (District Court of Offenbach am Main HRB 11653) as the dominant company, a control and profit transfer agreement was concluded on December 8, 2017. The shareholders meeting of December 12, 2017 approved him. In view of the further content, reference is made to the said treaty and to the decisions approving it. The company, as the acquiring entity, is merged with the INC Research GmbH with its registered office in Munich (District Court of Munich HRB 117325) in accordance with the merger agreement of August 23, 2019 and the consent decisions of the participating entities from the same day. The company is merged as the acquiring entity with its inVentiv Health Strategic Resourcing Germany GmbH registered office in Neu-Isenburg (District Court of Offenbach am Main HRB 48922) in accordance with the merger agreement of August 23, 2019 and the consent decisions of the participating entities from the same day.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Syneos Health Germany GmbH, Munich, Germany.
The visualizations for "Syneos Health Germany GmbH - Managing Director: Paul A. Mulholland, Ruth Wessendorff · Officer (2) · Control: inVentiv Health Holdings Germany GmbH · Control: inVentiv Health Holdings Germany GmbH · Merger: INC Research GmbH, inVentiv Health Strategic Resourcing Germany GmbH · Change of headquarters: inVentiv Health Germany GmbH · Address · Capital: €26,000 · Shareholder agreement · Company statute · Corporate Purpose"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
